Creative Biolabs

Constrained Peptide Library Construction

Posted by Creative BiolabsResponsive · Research Services and Capabilities · United States

Summary of the technology

Creative Biolabs developed a constrained peptide library construction technology, which offers constrained peptides with target-adapted cross-links. Our technology involves generating natural or semi-synthetic peptides with constrained structures to retain and improve the properties (e.g. stability, resistance to protease activity, protein binding affinity, intrinsic cell permeability, etc.) of the peptides.

Creative Biolabs

Creative Biolabs developed a Constrained Peptide Library Construction technology, which offers constrained peptides with target-adapted cross-links. Our technology involves generating natural or semi-synthetic peptides with constrained structures to retain/improve the properties (e.g., stability, resistance to protease activity, protein binding affinity, intrinsic cell permeability, etc.) of the peptides. Our platform has been optimized over the years to include Positional Stabilization Method, Positional Cyclization Method and Phage Display Peptide Library Method.More information, please visit the website: http://www.creative-biolabs.com/Constrained-Peptide-Library-Construction.html

Fees

inquiry

Technology Owner

Creative Biolabs

Small and Medium Enterprise

Bella Smith

Marketing Manager at Creative Biolabs

Related keywords

  • Biology / Biotechnology
  • Therapeutic
  • antibody
  • peptide library construction
  • recombinant

About Creative Biolabs

Small and Medium Enterprise from United States

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies [including phage display, bacterial display and yeast display]. We are also professional in conducting in depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. In addition, OEM services for bulk scale antibody manufacturing, including bacterial production of scFv, diabody, tandem scFv, miniantibody and Fab, and mammalian cell expression of minibody, chimeric IgG and IgG, are also available at the most competitive price in the industry.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.